Anticoagulation UK

26 August 2017

New Guidelines for the Management of Valvular Heart Disease

The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) have issued new guidelines for the management of valvular heart disease

Guidelines summarize and evaluate available evidence with the aim of assisting health professionals in selecting the best management strategies for an individual patient with a given condition. Guidelines and their recommendations should facilitate decision making of health professionals in their daily practice. However, the final decisions concerning an individual patient must be made by the responsible health professional(s) in consultation with the patient and caregiver as appropriate.

Why do we need new guidelines on valvular heart disease?

Since the previous version of the guidelines on the management of VHD was published in 2012, new evidence has accumulated, particularly on percutaneous interventional techniques and on risk stratification with regard to timing of intervention in VHD. This made a revision of the recommendations necessary.

Read the full guidelines at